Daniela Horakova's Colleagues at CEEOR
Daniela Horakova's Contact Details
+420 257 215 056
Central Bohemian Region,Czechia
CEEOR
Daniela Horakova's Company Details
CEEOR was funded in 2006 in Munich in Germany as a research and consulting firm specialising in analytical services to pharmaceutical, biotechnology and healthcare industries in Europe and occassionally beyond. The company soon gained a reputation as a customer-oriented and technology-focused market inteligence provider, triggering requests for clients to extend our services into other European countries. CEEOR has been headquartered in Prague, Czech Republic since 2008 with affiliates and business activities in other European countries. CEEOR was jointly founded by Dr. Aleš Tichopád, an expert in biotechnology and medical statistics, and Dr. Igor Gembula, an expert in marketing and information technologies, following and extending private consulting activities of both. CEEOR is specialised in the following activities: - Assembling and selling syndicated market inteligence data on pharmaceuticals from competitive markets. - Conducting primary market research for health care industry. - Supporting market access of innovative pharmaceuticals and health technologies by scientific research and analyses. - Developing software and computational methods for assembling storing and analysing various business intelligence data from pharmaceutical markets. - Providing business consulting to the pharmaceutical industry to measure the effectiveness of marketing and sales resources. - Conducting specialised commissioned research projects on pharmaceuticals after their market launch. - Providing scientific value evidence for pharmaceuticals and health technologies. Our customers include all the 10 largest pharmaceutical companies, as well as many other pharmaceutical companies, including large generic drug manufacturers. These customers derive benefit from CEEOR's data, consulting and commissioned research, all that in order to to manage, measure and optimise the marketing and sales performance, as well as to obtain rigorous value evidence for their products.